Drawing for OXFORD HEARTBEAT

USPTO serial 90028708

OXFORD HEARTBEAT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
INGRAM, KYLE G
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with OXFORD HEARTBEAT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard S. Finkelstein

Richard S. Finkelstein RC TRADEMARK COMPANY, LLCP.O. BOX 940BROOKFIELD, CT 06804United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for use in the simulation of blood flow; Downloadable computer software for use in the simulation of blood flow in relation to vessel and arterial diseases and abnormalities; Downloadable computer software for use in the simulation of blood flow in relation to vessel and arterial diseases and abnormalities for use in the medical and surgical field; Downloadable computer software for use in the simulation of blood flow in relation to vessel and arterial diseases and abnormalities for use in the veterinary field; Downloadable computer software for enabling the storage, retrieval, transmission and processing of data and information; Downloadable computer software for enabling the storage, retrieval, transmission and processing of data and information for medical purposes; Downloadable computer software for use in decision support systems and real time surgery support and visualisation; downloadable computer software for use in medical decision support systems; Downloadable computer software for medical image processing, anatomy visualisation and analysis, diagnosis and treatment simulations, predictions and suggestions for use in machine learning; Downloadable computer software for medical image processing, anatomy visualisation and analysis, diagnosis and treatment simulations, predictions and suggestions for use in machine learning for medical purposes; Downloadable computer software applications for the provision of access to advice and information; Downloadable computer software applications for the provision of access to medical advice and information; Downloadable computer software for use in creating computer generated models and simulations; Downloadable computer software for use in creating computer generated models and simulations of medical data; Virtual reality models being downloadable virtual reality software for use in medical teaching; Medical diagnostic simulators for use as teaching aids for surgeries for the treatment of blood vessel and arterial diseases and abnormalities; Electronic data processing apparatus; headmounted display apparatus, namely, Head-mounted video displays; computer display screens; scanners being data processing apparatus; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereofACTIVE—
035Compilation of information into computer databases; Data processing services; Data processing services in the medical and surgical field; Data processing services in the veterinary field; Database management; Database management in the medical field; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereofACTIVE—
042Computer modelling and design of computer-simulated models of human anatomy and treatment options related to vessel and arterial diseases and abnormalities; Computer modelling and design of computer-simulated models of human anatomy and treatment options related to vessel and arterial diseases and abnormalities including for the purposes of diagnostics, pre-operative planning and real time surgery support and visualization; Design and development of medical apparatus, namely, design and testing for new product development; Design and development of medical technology, namely, design and testing for new product development; Medical device design services being new product design services; Simulations of the deployment and manual manipulation of vascular medical devices being simulation of manual manipulation by clinicians in the nature of medical research services; Custom design of medical devices for others being new product design services; Software as a Service (SAAS) services featuring software for medical image processing, anatomy visualisation and analysis, diagnosis and treatment simulations, predictions and suggestions for medical use in the field of vascular and arterial diseases and abnormalities and their associated treatments; Software as a Service (SAAS) services featuring software for simulation of blood flow as relevant to vascular and arterial diseases and abnormalities and their associated treatments for use in the medical field; Software as a Service (SAAS) services featuring software for Simulation of blood flow as relevant to vascular and arterial diseases and abnormalities and their associated treatments for use in the veterinary field; Virtualizing surgical procedures, namely, services in the nature of computer modelling of surgical procedures; Computer modelling and simulating of human, biological and synthetic organs and fluids, being computer modelling services; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereofACTIVE—
044Providing on-line information in the medical field being the provision of medical information; Medical services; Minimally invasive surgical services; Rental of medical apparatus and instruments; Surgery; Veterinary services; Medical analysis services relating to patient treatment, namely, web-based vascular and arterial analysis services for medical diagnostic and treatment purposes; Medical and surgical diagnostic services, namely, medical diagnosis of Vascular and arterial disorders and abnormalities; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereofACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 9, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 9, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 11, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 11, 2026XAECEXAMINER'S AMENDMENT ENTERED—
May 11, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 11, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
May 11, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 23, 2026GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
Jan 23, 2026GNSFSUBSEQUENT FINAL EMAILED—
Jan 23, 2026CFRCSUBSEQUENT FINAL REFUSAL WRITTEN—
Jan 23, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 23, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 23, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 8, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 8, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 8, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 4, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 4, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 4, 2025DOCKASSIGNED TO EXAMINER—
Feb 7, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 5, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 5, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Jul 5, 2024CNSLSUSPENSION LETTER WRITTEN—
May 22, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 22, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 22, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2024AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jan 18, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 12, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 12, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 12, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 12, 2024ALIEASSIGNED TO LIE—
Jun 2, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 2, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Jun 2, 2023CNSLSUSPENSION LETTER WRITTEN—
May 11, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 11, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 11, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 29, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 29, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Dec 29, 2022CNSLSUSPENSION LETTER WRITTEN—
Nov 29, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 29, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 29, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 8, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 8, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Aug 8, 2022CNSLSUSPENSION LETTER WRITTEN—
Jul 5, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 13, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 15, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 13, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 13, 2021GNSLLETTER OF SUSPENSION E-MAILED—
May 13, 2021CNSLSUSPENSION LETTER WRITTEN—
Apr 14, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 14, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 14, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 14, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 14, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 14, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 4, 2020DOCKASSIGNED TO EXAMINER—
Jul 28, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 3, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance